Cardiometabolic multimorbidity (CMM) among older adults in India

Manish Barik1, Sushree Nibedita Panda2

  • 1IMPACT Global Consulting, New Delhi, India. manishbarik2.bbsr@gmail.com.

PubMed

Insights

Cardiometabolic multimorbidity (CMM) affects over 23% of older Indians, with higher rates in women and urban dwellers. Addressing disparities in CMM prevalence is crucial for India

Area of Science:

  • Gerontology
  • Public Health
  • Epidemiology

Background:

  • Cardiometabolic multimorbidity (CMM) is a growing concern in aging populations, linked to adverse health outcomes.
  • Prevalence is rising due to shared risk factors, but data from low- and middle-income countries like India is limited.
  • This study focuses on CMM prevalence and correlates in older Indian adults.

Purpose of the Study:

  • To investigate the prevalence of cardiometabolic multimorbidity (CMM) in Indian adults aged 45 and older.
  • To identify socio-demographic and regional correlates associated with CMM in this population.
  • To inform targeted public health interventions for CMM in India.

Main Methods:

  • Analysis of data from 59,764 participants (aged 45+) from the Longitudinal Ageing Study in India (LASI) wave 1 (2017-2019).
  • CMM defined as co-occurrence of two or more conditions: hypertension, diabetes, coronary heart disease, stroke, obesity, hypercholesterolemia.
  • Multivariable logistic regression used to identify correlates of CMM, reporting adjusted odds ratios (AOR).

Main Results:

  • Overall CMM prevalence was 25.1% (females: 27.3%, males: 23.04%), higher in the 60-74 age group.
  • CMM was more prevalent in urban areas, wealthier socioeconomic groups, and among individuals with higher education.
  • Significant regional disparities observed, with highest rates in Southern and Western India; caste also showed significant associations.

Conclusions:

  • Cardiometabolic multimorbidity (CMM) presents a significant and increasing burden among middle-aged and older Indians.
  • Higher prevalence in females, urban residents, and wealthier groups, alongside regional and caste disparities, necessitates targeted interventions.
  • Early screening and comprehensive primary care are essential for managing CMM as India's population ages.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
282
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
465